What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday?
On Friday, Vir Biotechnology, Inc. (NASDAQ:VIR) announced end-of-treatment data from Part B of the MARCH Phase 2 study ...
Arbutus Biopharma announces new data from IM-PROVE I Phase 2a trial
Arbutus Biopharma (ABUS) announced new data from its IM-PROVE I Phase 2a clinical trial showing that six doses of imdusiran, the ...